Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 72 | 626 | 275 | 1,136 | 89 |
| Gross Profit | 72 | 626 | 275 | 1,136 | 89 |
| Operating Expenses | 7,320 | 6,581 | 6,240 | 20,753 | 11,869 |
| Operating Income | -7,248 | -5,955 | -5,965 | -19,616 | -11,780 |
| Interest Expense | 2,516 | 1,209 | 829 | 0 | 0 |
| Other Income | 7,891 | 4,413 | -171 | -392 | 923 |
| Pre-tax Income | -1,873 | -2,751 | -6,965 | -20,009 | -10,857 |
| Income Tax | 14 | 52 | 28 | 31 | N/A |
| Net Income Continuous | -1,886 | -2,803 | -6,992 | -20,039 | -10,857 |
| Net Income | $-1,886 | $-2,803 | $-6,992 | $-20,039 | $-10,857 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.06 | -0.30 | -0.18 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.06 | -0.30 | -0.18 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.06 | -0.30 | -0.18 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.06 | -0.30 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | -0.06 | -0.30 | -0.18 |
| EBITDA(a) | $-7,238 | $-5,945 | $-5,960 | $-19,606 | $-11,769 |